Clinical trial
Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
NCT00086502 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00086502 |
|---|---|
| Title | Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus |
| Official title | A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK0431 to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Pioglitazone Therapy |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Comparator: Sitagliptin, Comparator: Placebo, Comparator: Pioglitazone, Metformin |
| Enrollment | 353 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Jul 5, 2004 |
| Last update posted | Feb 5, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: